The impact of insulin on patient quality of life

https://doi.org/10.53730/ijhs.v7nS1.15083

Authors

  • Abdulaziz Alamri KSA, KAMC-Riyadh
  • Ahmad Bawazeer KSA, KAMC-Riyadh
  • Tariq Almotiri KSA, KAMC-Riyadh
  • Sattam Alharbi KSA, KAMC-Riyadh
  • Delyal Alshammari KSA, KAMC-Riyadh
  • Bader Alnasser KSA, KAMC-Riyadh
  • Hani Alswayeh KSA, KAMC-Riyadh
  • Sari Alrasheedi KSA, KAMC-Riyadh

Keywords:

Diabetes mellitus, Type 1 diabetes, impact of insulin

Abstract

Diabetes mellitus is a chronic metabolic disorder characterized by elevated blood glucose levels due to the body's inability to effectively produce or utilize the hormone insulin (American Diabetes Association, 2022). Insulin is a critical hormone produced by the pancreas that enables the body to regulate blood sugar levels by facilitating the uptake of glucose into cells for energy or storage (Wilcox, 2005). Without sufficient insulin production or function, blood glucose levels can become dangerously high, leading to a variety of serious health complications. There are two main types of diabetes, type 1 and type 2, which differ in their underlying causes and treatment approaches. Type 1 diabetes is an autoimmune disorder where the body mistakenly attacks and destroys the insulin-producing beta cells in the pancreas, resulting in an absolute insulin deficiency (Atkinson et al., 2014). Type 2 diabetes is typically associated with lifestyle factors such as obesity and physical inactivity, and is characterized by the body's reduced sensitivity and responsiveness to insulin, a condition known as insulin resistance (Kahn, 2014). Regardless of the type, diabetes requires careful management through lifestyle modifications and/or pharmaceutical interventions, including the administration of exogenous insulin,,, 

Downloads

Download data is not yet available.

References

American Diabetes Association. (2018). Economic costs of diabetes in the U.S. in 2017. Diabetes Care, 41(5), 917-928. DOI: https://doi.org/10.2337/dci18-0007

American Diabetes Association. (2022). Diagnosis and classification of diabetes mellitus. Diabetes Care, 45(Supplement 1), S17-S38.

Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014). Type 1 diabetes. The Lancet, 383(9911), 69-82. DOI: https://doi.org/10.1016/S0140-6736(13)60591-7

Barnard, K. D., Lloyd, C. E., & Skinner, T. C. (2007). Systematic literature review: quality of life associated with insulin pump use in type 1 diabetes. Diabetic Medicine, 24(6), 607-617. DOI: https://doi.org/10.1111/j.1464-5491.2007.02120.x

Beran, D., & Yudkin, J. S. (2010). Diabetes care in sub-Saharan Africa. The Lancet, 375(9733), 2254-2266. DOI: https://doi.org/10.1016/S0140-6736(10)60550-8

Cemeroglu, A. P., Can, A., Korkmaz, U., Hekim, N., & Soran, M. (2010). Evaluation of the long-term efficacy and safety of insulin pen devices in pediatric patients with type 1 diabetes. Journal of Diabetes Science and Technology, 4(5), 1114-1120.

Cryer, P. E. (2008). The barrier of hypoglycemia in diabetes. Diabetes, 57(12), 3169-3176. DOI: https://doi.org/10.2337/db08-1084

DCCT Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329(14), 977-986. DOI: https://doi.org/10.1056/NEJM199309303291401

de Wijk, E., Bonfrer, J. M., van Rooijen, G. W., Dekker, J. M., & Snoek, F. J. (2015). Perspectives on initiation and intensification of insulin therapy among patients with type 2 diabetes in the Netherlands

Published

08-07-2023

How to Cite

Alamri, A., Bawazeer, A., Almotiri, T., Alharbi, S., Alshammari, D., Alnasser, B., Alswayeh, H., & Alrasheedi, S. (2023). The impact of insulin on patient quality of life. International Journal of Health Sciences, 7(S1), 3398–3405. https://doi.org/10.53730/ijhs.v7nS1.15083

Issue

Section

Peer Review Articles

Most read articles by the same author(s)